Department of Neurosurgery

News

Researchers Announce Breakthrough in Brain Cancer Vaccine Trial

“PROVIDENCE, R.I. (WPRI) — Lifespan researchers say they have made a major breakthrough in fighting brain cancer.

The Lifespan Cancer Institute held a news conference at Rhode Island Hospital to present results from a vaccine trial for glioblastoma, the most common and lethal form of brain cancer.

According to researchers, the Phase III clinical trial of the DCVax-L cancer vaccine shows that it can expand the life of patients with both newly diagnosed and recurrent glioblastoma.

‘The nice thing about it is it’s non-toxic. Just like getting a vaccine for the flu or COVID that we are all familiar with,’ said Dr. Steven Toms, director of the Brain Tumor and Stereotactic Radiosurgery Program.”

Read the full article Here

Watch the full press conference Here

Featured

Steven A. Toms, MD

Professor of Neurosurgery and Radiation Oncology
Vice-Chair, Department of Neurosurgery
Director, Brain Tumor and Stereotactic Radiosurgery Program
Co-Director, Molecular Neuroscience and Neuro-Oncology Laboratory

Heinrich Elinzano, MD

Associate Professor of Neurology and Medicine, Clinician Educator
Co-Director, Brain Cancer Committee
Co-Director, Brown University Oncology Research Group
Neuro-Oncology Medical Lead, Lifespan Cancer Institute